Hims & Hers Health, Inc.

Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs's next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs has 872.09M shares outstanding.

As of June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs posted a negative return on equity (ROE) of -32.03, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.16, reflecting losses generated across the asset base. The company generates approximately 1.15M in revenue per employee across its workforce of 2,240.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.09 indicates how many times Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs recorded an income tax benefit of -21.58M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -163.61M and -142.03M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs generated 2.58B in revenue and converted that into -142.03M in net income, yielding earnings per share of -0.16. EBITDA reached -67.33M, while operating income came in at -154.52M.

As of June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs holds 841.05M in cash and equivalents against 1.55B in total debt, resulting in a net debt position of 755.49M. Total book value stands at 324.07M, with working capital of -98.62M providing operational flexibility.

Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs produced 263.45M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -201.82M in capital expenditures, free cash flow totaled 61.63M - equivalent to 0.07 per share.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Registered Shs A Cert Deposito Arg Repr 0.25 Shs posted a gross margin of 68.43, reflecting its pricing power and cost economics. The operating margin of -5.99 and net profit margin of -5.51 provide insight into operational efficiency.